rais po best case
rais po
rais ew po follow ew better expect
risk tavr transcathet aortic valv replac data yesterday american colleg
cardiolog meet new orlean rais number
convict well consensu year number think street
underestim ew abil drive oper leverag ew heaviest
period trial spend subsid ep estim
consensu rais po suggest anoth upsid
potenti ew arriv po assum ew current multipl
ep discount back would surpris see upsid ew
manifest next month see strong addit catalyst near term
ew present mitral valv data may year data could acceler
tavr market soon reiter buy rate
big risk
number surgic data base strongli suggest number surgeri take
place us risk patient could candid tavr around
assum expans address market beyond risk valv surgeri
take place today patient could candid tavr overli
conserv view us tavr market would expand close
current us tavr market
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
edward lifesci leader emerg
field transcathet heart valv replac
one visibl innov excit
market medic devic sector
ew heart valv busi gener
compani total revenu critic care
busi account total sale
almost attent focus
compani today due on-going pioneer
role develop transcathet heart valv
ew stand-alon tavr transcathet
aortic valv replac name one
largest fastest grow med-tech market
current believ tavr stand alongsid
coronari stent core technolog
catheter lab futur
posit ew current pipelin tmvr
see signific potenti catalyst ew
approv indic expans
po base ew ep discount back target
multipl premium peer trade earn think ew trade
signific premium peer due belief potenti mitral tavr
downsid risk price object tavi market develop risk rel
street high expect competit risk relat ew core tavi busi
risk market opportun technolog could smaller
assum upsid risk price object potenti deeper penetr
market larger market opportun model untreat high low
moder risk patient seek tavi given less invas natur
bob hopkin herebi certifi view express research report accur
reflect person view subject secur issuer also certifi
part compens directli indirectli relat specif
recommend view express research report
becton dickinson compani
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
